Our findings regarding the influence of SOD2 and GPX1 polymorphisms on the laboratory biochemical parameters might be of clinical importance, since we found that COVID-19 patients with low-activity alleles of these genes have higher levels of inflammation and coagulation parameters. This evidence concerns the gene GPX1 and COVID-19.